Reprimo, a new candidate mediator of the p53-mediated cell cycle arrest at the G2 phase

被引:160
作者
Ohki, R
Nemoto, J
Murasawa, H
Oda, E
Inazawa, J
Tanaka, N
Taniguchi, T
机构
[1] Univ Tokyo, Grad Sch Med, Dept Immunol, Bunkyo Ku, Tokyo 1130033, Japan
[2] Univ Tokyo, Fac Med, Bunkyo Ku, Tokyo 1130033, Japan
[3] Tokyo Med & Dent Univ, Med Res Inst, Dept Mol Cytogenet, Div Genet,Bunkyo Ku, Tokyo 1138519, Japan
关键词
D O I
10.1074/jbc.C000235200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A novel gene, Reprimo, in which induction in cells exposed to X-irradiation is dependent on p53 expression, has been isolated. Ectopic p53 expression results in the induction of its mRNA. Reprimo is a highly glycosylated protein and, when ectopically expressed, it is localized in the cytoplasm and induces G(2) arrest of the cell cycle. In the arrested cells, both Cdc2 activity and nuclear translocation of cyclin El are inhibited, suggesting the involvement of Reprimo in the Cdc2.cyclin B1 regulation pathway. Thus, Reprimo may be a new member involved in the regulation of p53-dependent G(2) arrest of the cell cycle.
引用
收藏
页码:22627 / 22630
页数:4
相关论文
共 40 条
  • [1] MDM2 EXPRESSION IS INDUCED BY WILD TYPE-P53 ACTIVITY
    BARAK, Y
    JUVEN, T
    HAFFNER, R
    OREN, M
    [J]. EMBO JOURNAL, 1993, 12 (02) : 461 - 468
  • [2] Carrier F, 1999, MOL CELL BIOL, V19, P1673
  • [3] 14-3-3σ is required to prevent mitotic catastrophe after DNA damage
    Chan, TA
    Hermeking, H
    Lengauer, C
    Kinzler, KW
    Vogelstein, B
    [J]. NATURE, 1999, 401 (6753) : 616 - 620
  • [4] Regulation of p53 downstream genes
    El-Deiry, WS
    [J]. SEMINARS IN CANCER BIOLOGY, 1998, 8 (05) : 345 - 357
  • [5] Detailed studies on substrate structure requirements of glycoamidases A and F
    Fan, JQ
    Lee, YC
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (43) : 27058 - 27064
  • [6] p53 in growth control and neoplasia
    Gottlieb, TM
    Oren, M
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 1996, 1287 (2-3): : 77 - 102
  • [7] The hallmarks of cancer
    Hanahan, D
    Weinberg, RA
    [J]. CELL, 2000, 100 (01) : 57 - 70
  • [8] Cell type-specific inhibition of p53-mediated apoptosis by mdm2
    Haupt, Y
    Barak, Y
    Oren, M
    [J]. EMBO JOURNAL, 1996, 15 (07) : 1596 - 1606
  • [9] 14-3-3σ is a p53-regulated inhibitor of G2/M progression
    Hermeking, H
    Lengauer, C
    Polyak, K
    He, TC
    Zhang, L
    Thiagalingam, S
    Kinzler, KW
    Vogelstein, B
    [J]. MOLECULAR CELL, 1997, 1 (01) : 3 - 11
  • [10] P53 MUTATIONS IN HUMAN CANCERS
    HOLLSTEIN, M
    SIDRANSKY, D
    VOGELSTEIN, B
    HARRIS, CC
    [J]. SCIENCE, 1991, 253 (5015) : 49 - 53